COVID-19 pandemic The Therapeutic Goods Administration grants provisional approval for the Moderna COVID-19 vaccine for use in children between the ages of 12 and 17. TGA approves Moderna COVID-19 vaccine for children between 12 and 17 © 9 News Sources: 9 News